this finding , together with the possible retardation of the progression of the disease with selegiline suggests that dopaminergic treatment in early parkinson 's disease should be initiated using a dopamine agonist such as lisuride in combination with selegiline and levodopa .
C0030567
parkinson 's disease
C0036579
selegiline